Quadrant Capital Group LLC Moderna, Inc. Transaction History

Quadrant Capital Group LLC

$1.34 Billion
Q2 2024

A detailed history of Quadrant Capital Group LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 3,331 shares of MRNA stock, worth $219,013. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,331

Previous 2,916 14.23%

Holding current value

$219,013

Previous $310,000 27.42%

% of portfolio

0.03%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$101.21 - $166.61 $42,002 - $69,143	415 Added 14.23%	3,331 $395,000
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $20,830 - $28,167	244 Added 9.13%	2,916 $310,000
Q4 2023 Feb 08, 2024	BUY	$69.51 - $104.43 $12,998 - $19,528	187 Added 7.53%	2,672 $265,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $67,197 - $88,247	697 Added 38.98%	2,485 $256,000
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $51,903 - $70,312	-438 Reduced 19.68%	1,788 $217,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $63,081 - $91,614	-465 Reduced 17.28%	2,226 $341,000
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $116,722 - $207,099	986 Added 57.83%	2,691 $483,000
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $22,669 - $37,282	-192 Reduced 10.12%	1,705 $202,000
Q2 2022 Aug 09, 2022	SELL	$117.13 - $176.59 $4,450 - $6,710	-38 Reduced 1.96%	1,897 $271,000
Q1 2022 May 06, 2022	BUY	$126.46 - $235.05 $26,935 - $50,065	213 Added 12.37%	1,935 $333,000
Q4 2021 Feb 01, 2022	SELL	$225.82 - $368.51 $10,613 - $17,319	-47 Reduced 2.66%	1,722 $437,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $66,348 - $144,856	299 Added 20.34%	1,769 $681,000
Q2 2021 Aug 09, 2021	BUY	$129.91 - $234.98 $17,407 - $31,487	134 Added 10.03%	1,470 $345,000
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $31,443 - $53,562	288 Added 27.48%	1,336 $175,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $27,808 - $71,850	423 Added 67.68%	1,048 $109,000
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $2,988 - $5,216	55 Added 9.65%	625 $44,000
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $36,345 - $98,000	-1,225 Reduced 68.25%	570 $37,000
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $31,915 - $56,686	1,795 New	1,795 $54,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Moderna, Inc. Transaction History